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Case presentation
A 56-year-old male patient with a history of
Friedreich ataxia was referred to the cardiac cath-
eterization laboratory after electromechanical resus-
citation due to ventricular fibrillation. Two hours
before, trans-urethral intra-vesical botulinum toxin
A injection (300U) had been performed because
of neurogenic bladder dysfunction. His past medical
history was positive for hypertension and smoking,
but negative for any cardiovascular event.
On admission, laboratory analysis had been un-
remarkable and baseline ECG showed incomplete
right bundle branch block and T-wave inversions
in leads V1–V2. Postrescuscitation, new preterminal
T-wave inversions were noted in the inferior leads
and in leads I, and V3–6, along with troponin T
elevation (0.72 mg/l). In the course, dynamic discrete
ST segment elevations developed in leads V1–V3.
Unfractionated heparin, acetylsalicylic acid and clo-
pidogrel were administered for suspected acute cor-
onary syndrome. Coronary angiography revealed
thrombotic occlusion of the right coronary artery
with a large thrombus extending from the proximal
to the mid segment (Figure 1A). Of note, there were
no coronary artery spasms observed; in particular,
vascular tone was unchanged after intracoronary
nitroglycerine administration. Immediate percutan-
eous coronary intervention was performed and the
vessel reopened by means of thrombus aspiration
using a diver catheter and the utilization of two
drug-eluting stents (Biomatrix). Final angiographic
documentation revealed complete restoration of
flow and normal left ventricular wall motions with
preserved left ventricular systolic function
(Figure 1B). The post-interventional course on the
intensive care unit (ICU) was unremarkable and
the patient was transferred to the regular ward
1 day after admission.
Discussion
We describe a case of acute myocardial infarction in
a patient with Friedreich ataxia following intra-
vesical botulinum toxin A injection.
Cardiac involvement is frequently observed in
Friedreich ataxia. However, acute coronary syn-
dromes have rarely been described in these patients.
Typically, hypertrophic cardiomyopathy, which was
excluded in our patient using echocardiography,
and an abnormal repolarization phase and arrhyth-
mias are detected.1
Botulinum toxin A impedes neuromuscular trans-
mission causing muscle weakening. It blocks acetyl-
choline release in nerve terminals by cleaving
SNARE proteins, thereby preventing fusion of acetyl-
choline vesicles with the cell membrane. Botulinum
toxin A is widely used for cosmetic applications, and
in the treatment of muscle spasms, chronic pain
syndroms or bladder dysfunction.2
Botulinum toxin A is assumed to have mainly
local effects. However, systemic side effects have
been described. Hence, botulinum toxin A might
also affect vasoreactivity or interact with the
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coagulation cascade, endothelial cells or platelets
and in turn promote thrombus formation. Indeed,
single cases of myocardial infarction, pulmonary
embolism, and even death have been reported
after botulinum toxin A injection.3 The effect of
botulinum toxin A on vasoreactivity is not fully
understood. In rat, aortic rings suspended in organ
chambers, contractions to potassium chloride (KCl)
and norepinephrine were completely inhibited
after incubation with botulinum toxin.4
Furthermore, in Sprague Dawley rats, femoral
vessel diameter was increased after subcutaneous
botulinum toxin injection.5 Hence, and in line
with the coronary angiogram, vasospasms as the pri-
mary cause of the acute myocardial infarction
appear unlikely in this patient. Rather, the extensive
thrombus burden suggests a pro-thrombotic state. As
we did not exclude a patent foramen ovale in our
patient, paradoxical embolism cannot be ruled out
completely. However, such events are rare and typ-
ically present with abrupt distal coronary occlusion
suggestive of embolism on angiogram. In any case,
pro-thrombotic effects of botulinum toxin A have
not been described so far, both, in vitro and
in vivo, and may be assumed.
The temporal coincidence of botulinum toxin
injection and the onset of myocardial infarction
in our patient suggest a causal relationship.
Importantly, as botulinum toxin injections are
widely performed, also in elderly patients with car-
diovascular disease, and as acute coronary syn-
dromes are serious complications, clinicians
should be cautious using botulinum toxin A because
of the risk of serious side effects and patients have
to be monitored carefully after botulinum toxin
injections.
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Figure 1. (A) Coronary angiography revealing thrombotic
occlusion of proximal and mid segments of the right cor-
onary artery with collateral flow from the left anterior des-
cending artery. (B) Coronary angiography of the right
coronary artery following percutaneous coronary
intervention.
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